QUEST DIAGNOSTICS ($DGX) posted quarterly earnings results for Q3 2026 on Thursday, October 22nd. The company reported earnings of $3.00 per share, beating estimates of $2.89 by $0.11. The company also reported revenue of $3,097,000,000, beating estimates of $3,076,038,971 by $20,961,029.
You can see Quiver Quantitative's $DGX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
QUEST DIAGNOSTICS Insider Trading Activity
QUEST DIAGNOSTICS insiders have traded $DGX stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 3 sales selling 22,677 shares for an estimated $5,513,082.
- J. E. DAVIS (CEO and President) has made 0 purchases and 2 sales selling 20,000 shares for an estimated $4,368,600.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) sold 8,147 shares for an estimated $1,629,400
- MARK E DELANEY (SVP & Chief Commercial Officer) sold 1,600 shares for an estimated $376,288
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
QUEST DIAGNOSTICS Hedge Fund Activity
We have seen 519 institutional investors add shares of QUEST DIAGNOSTICS stock to their portfolio, and 438 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 3,520,438 shares (+inf%) to their portfolio in Q2 2026, for an estimated $746,156,834
- PRICE T ROWE ASSOCIATES INC /MD/ removed 853,001 shares (-13.5%) from their portfolio in Q2 2026, for an estimated $180,793,561
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 773,711 shares (+inf%) to their portfolio in Q2 2026, for an estimated $163,988,046
- BOSTON PARTNERS added 732,241 shares (+18.3%) to their portfolio in Q2 2026, for an estimated $155,198,479
- EDGEPOINT INVESTMENT GROUP INC. added 586,496 shares (+35.3%) to their portfolio in Q2 2026, for an estimated $124,307,827
- VICTORY CAPITAL MANAGEMENT INC removed 575,866 shares (-27.1%) from their portfolio in Q2 2026, for an estimated $122,054,798
- FMR LLC added 456,517 shares (+48.5%) to their portfolio in Q2 2026, for an estimated $96,758,778
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
QUEST DIAGNOSTICS Government Contracts
We have seen $136,597,329 of award payments to $DGX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FY27 TASK ORDER - 10/1/2026 - 6/30/2027: $7,162,140
- PRIMARY REFERENCE LABORATORY TESTING / COURIER SERVICES / PHLEBOTOMY: $3,174,300
- VISN 12 MULTI-SITE REFERENCE LABORATORY TESTING SERVICES FY27 TO: $3,110,000
- REFERENCE LAB TESTS: $2,748,684
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
